91 related articles for article (PubMed ID: 6117529)
1. Human chorionic gonadotropin in intrauterine device users.
Shalit A; Jaschevatzky OE; Kampf D; Leiserowitz DM; Grünstein S
Int J Fertil; 1980; 25(2):134-6. PubMed ID: 6117529
[TBL] [Abstract][Full Text] [Related]
2. Chorionic gonadotropin in women fitted with intrauterine device.
Yarkoni S; Zer TA; Schenker JG
Infertility; 1980; 3(1):23-7. PubMed ID: 12263338
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
[TBL] [Abstract][Full Text] [Related]
4. Absence of chorionic gonadotropin in sera of women who use intrauterine devices.
Segal SJ; Alvarez-Sanchez F; Adejuwon CA; Brache de Mejia V; Leon P; Faundes A
Fertil Steril; 1985 Aug; 44(2):214-8. PubMed ID: 4018277
[TBL] [Abstract][Full Text] [Related]
5. Human chorionic gonadotrophin (hCG) in IUD users.
Dhont M; Thiery M; Vanlancker M
IRCS J Med Sci; 1984 Sep; 12(9):862. PubMed ID: 12340100
[TBL] [Abstract][Full Text] [Related]
6. Detection of beta subunit HCG in plasma of IUD users as an indication of frequency of conception.
Nilsson CG; Lähteenmäki P; Luukkainen T
Int J Fertil; 1979; 24(2):134-7. PubMed ID: 40908
[TBL] [Abstract][Full Text] [Related]
7. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures.
Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC
J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130
[TBL] [Abstract][Full Text] [Related]
8. Absence of circulating chorionic gonadotropin in wearers of intrauterine contraceptive devices.
Klein TA; Mishell DR
Am J Obstet Gynecol; 1977 Nov; 129(6):626-8. PubMed ID: 920763
[TBL] [Abstract][Full Text] [Related]
9. Production of human chorionic gonadotropin during the normal menstrual cycle.
Cole LA; Gutierrez JM
J Reprod Med; 2009 Apr; 54(4):245-50. PubMed ID: 19438167
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of human chorionic gonadotropin during the second half of the menstrual cycle in plasma of regularly menstruating women users of copper IUds.
Capitanio GL; Conte N; Ragni N; Rossato P; Pedretti E
Acta Eur Fertil; 1978 Mar; 9(1):11-9. PubMed ID: 696185
[TBL] [Abstract][Full Text] [Related]
11. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
[TBL] [Abstract][Full Text] [Related]
12. Hormonal profile in IUD users.
Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
[TBL] [Abstract][Full Text] [Related]
13. Urinary human chorionic gonadotropin among intrauterine device users: detection with a highly specific and sensitive assay.
Wilcox AJ; Weinberg CR; Armstrong EG; Canfield RE
Fertil Steril; 1987 Feb; 47(2):265-9. PubMed ID: 3817172
[TBL] [Abstract][Full Text] [Related]
14. Hormonal characteristics in the early luteal phase of conceptive and nonconceptive menstrual cycles.
Chen J; Qiu Q; Lohstroh PN; Overstreet JW; Lasley BL
J Soc Gynecol Investig; 2003 Jan; 10(1):27-31. PubMed ID: 12517590
[TBL] [Abstract][Full Text] [Related]
15. A radioimmunoassay system for LH based on the antigenic similitude of LH with HCG: methodology and applications.
Simionescu L; Dimitriu V; Aman E; Muşeţeanu P; Popa M; Marinescu I; Maximilian C
Endocrinologie; 1985; 23(4):253-63. PubMed ID: 3841409
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
17. Levels of HCG in subjects using the Progestasert(TM) intrauterine progesterone systems.
Custo GM; Carenza L; Pala A
Contraception; 1980 Mar; 21(3):311-7. PubMed ID: 6771092
[TBL] [Abstract][Full Text] [Related]
18. Absence of hCG-like activity in the blood of women fitted with intra-uterine contraceptive devices.
Sharpe RM; Wrixon W; Hobson BM; Corker CS; McLean HA; Short RV
J Clin Endocrinol Metab; 1977 Sep; 45(3):496-9. PubMed ID: 903400
[TBL] [Abstract][Full Text] [Related]
19. Detection of human chorionic gonadotropin in blood of regularly bleeding women using copper intrauterine contraceptive devices.
Landesman R; Coutinho EM; Saxena BB
Fertil Steril; 1976 Sep; 27(9):1062-6. PubMed ID: 964399
[TBL] [Abstract][Full Text] [Related]
20. Presence of elevated circulating levels of LH during the pre-menstrual period in some copper IUD users and the possibility of their confusion with hCG.
Dattatreyamurty B; Joshi J; Mehta S; Virkar KD; Sheth AR
Contraception; 1979 Mar; 19(3):213-21. PubMed ID: 455978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
